| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $11,083,100 | 13 | 100 |
| Wilder Thomas | director | 0 | $0 | 1 | $57,794 | $-57,794 |
| Grewal Harpreet | director | 0 | $0 | 4 | $162,601 | $-162,601 |
| Yuen Maggie | Chief Financial Officer | 0 | $0 | 1 | $832,474 | $-832,474 |
| Roberts Johanna | EVP, Gen. Counsel & Secretary | 0 | $0 | 4 | $967,302 | $-967,302 |
| Bose Arani | director | 0 | $0 | 3 | $9.06M | $-9.06M |
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron …
Over the last 12 months, insiders at Penumbra, Inc. have bought $0 and sold $11.08M worth of Penumbra, Inc. stock.
On average, over the past 5 years, insiders at Penumbra, Inc. have bought $0 and sold $36.59M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 700 shares for transaction amount of $109,480 was made by O'Rourke Bridget (director) on 2018‑05‑25.
| 2026-04-02 | Sale | Grewal Harpreet | director | 100 0.0003% | $328.22 | $32,822 | -2.86% | |
| 2026-03-02 | Sale | Yuen Maggie | Chief Financial Officer | 2,432 0.0062% | $342.30 | $832,474 | -5.86% | |
| 2026-01-06 | Sale | Grewal Harpreet | director | 186 0.0005% | $312.64 | $58,151 | +2.11% | |
| 2026-01-02 | Sale | Wilder Thomas | director | 186 0.0005% | $310.72 | $57,794 | +4.51% | |
| 2025-12-11 | Sale | Bose Arani | director | 15,000 0.038% | $308.82 | $4.63M | +3.63% | |
| 2025-12-05 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 300 0.0008% | $300.13 | $90,039 | +7.27% | |
| 2025-12-02 | Sale | Grewal Harpreet | director | 100 0.0003% | $292.98 | $29,298 | +12.06% | |
| 2025-12-01 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0015% | $294.94 | $176,966 | +10.53% | |
| 2025-11-25 | Sale | Bose Arani | director | 7,500 0.0199% | $300.19 | $2.25M | +7.87% | |
| 2025-11-25 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 1,800 0.0048% | $300.06 | $540,108 | +7.87% | |
| 2025-11-21 | Sale | Bose Arani | director | 7,500 0.0193% | $290.56 | $2.18M | +11.68% | |
| 2025-11-10 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0015% | $266.98 | $160,189 | +18.75% | |
| 2025-11-04 | Sale | Grewal Harpreet | director | 186 0.0005% | $227.58 | $42,330 | +36.62% | |
| 2025-10-02 | Sale | Grewal Harpreet | director | 186 0.0005% | $248.61 | $46,241 | +26.18% | |
| 2025-10-01 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0015% | $249.70 | $149,820 | +28.13% | |
| 2025-10-01 | Sale | Wilder Thomas | director | 186 0.0005% | $253.93 | $47,231 | +28.13% | |
| 2025-09-03 | Sale | Elsesser Adam | CEO | 15,800 0.0405% | $269.65 | $4.26M | +18.48% | |
| 2025-09-02 | Sale | Roberts Johanna | EVP, Gen. Counsel & Secretary | 600 0.0015% | $270.58 | $162,347 | +18.55% | |
| 2025-09-02 | Sale | Grewal Harpreet | director | 186 0.0005% | $272.19 | $50,627 | +18.55% | |
| 2025-08-20 | Sale | Elsesser Adam | CEO and President | 15,900 0.0406% | $254.53 | $4.05M | +24.63% |
| Evans Robert D. | EVP, Gen. Counsel & Secretary | 15667 0.0397% | $5.01M | 1 | 35 | +44.13% |
| O'Rourke Bridget | director | 5373 0.0136% | $1.72M | 1 | 27 | <0.0001% |
| Increased Positions | 207 | +39.13% | 4M | +10.28% |
| Decreased Positions | 235 | -44.42% | 4M | -9.56% |
| New Positions | 79 | New | 2M | New |
| Sold Out Positions | 55 | Sold Out | 261,997 | Sold Out |
| Total Postitions | 501 | -5.29% | 37M | +0.72% |
| Fmr Llc | $1.82M | 15.11% | 5.89M | +34,250 | +0.58% | 2025-09-30 |
| Blackrock, Inc. | $1.29M | 10.7% | 4.17M | -42,225 | -1% | 2025-09-30 |
| Vanguard Group Inc | $1.19M | 9.84% | 3.84M | -25,172 | -0.65% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $555,182.00 | 4.6% | 1.79M | +420,266 | +30.59% | 2025-09-30 |
| State Street Corp | $360,459.00 | 2.99% | 1.16M | -5,792 | -0.49% | 2025-09-30 |
| Citadel Advisors Llc | $300,446.00 | 2.49% | 970,998 | +752,006 | +343.39% | 2025-09-30 |
| Baillie Gifford & Co | $281,122.00 | 2.33% | 908,546 | -13,581 | -1.47% | 2025-09-30 |
| Rtw Investments, Lp | $268,112.00 | 2.22% | 866,499 | +2,946 | +0.34% | 2025-09-30 |
| Jpmorgan Chase & Co | $261,057.00 | 2.16% | 843,697 | +92,828 | +12.36% | 2025-09-30 |
| Clearbridge Investments, Llc | $234,388.00 | 1.94% | 757,508 | +58,848 | +8.42% | 2025-09-30 |